A team with a shared passion for genetics and better health

Arndt is a Professor at the University of Rostock, Germany, multi-entrepreneur in biotech, founder and former CEO of CENTOGENE. He received his MD in 1985 and was granted a tenure track professorship for clinical neurology in 1997 at the University of Rostock. In 2008, Arndt was appointed Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock. Arndt has initiated multiple international multicenter studies in genetic disorders with an extensive track record in medical and scientific publications.

Niclas joined Arcensus in January 2022 after working with Arcensus already as Co-Founder and Partner of his company Morrow Ventures. Niclas is a dedicated founder and entrepreneur with a focus on establishing new digital business models. He launched numerousventures and international digital projects.
Before Morrow, Niclas was Partner and President of the Board of a Boutique-Strategy Consultancy with focuson innovation and new business building.

Christine has worked for 20+ years as a strategy and finance executive in fast-growing, innovative and international IT and life science businesses.

She has extensive experience in strategy and finance in internationally active, innovative and, above all, growing companies. Christine holds a degree in Business Economics and was most recently CFO at CENTOGENE, a global diagnostics company. There, she was responsible for developing the company's financial architecture and expansion strategy and successfully supported growth corresponding to more than a tenfold increase in sales within five years. Furthermore, she has held several management positions in biotechnology and technology companies, including curasan AG, ProBioGen AG, OD-OS GmbH, SPM Technologies GmbH and SAP Systems Integration AG.

Gabriela holds a PhD in Natural Science from University of Cologne, Germany and has been an active researcher in Human Genetics for almost 15 years. Her discovery and characterisation of the first protective modifier of autosomal recessive spinal muscular atrophy [Science, 2008] gained her several awards. She is a highly motivated and experienced scientist in analysis, interpretation and utilisation of genetic information within clinical context, efficiently turning big data into knowledge-based products. She acted as SVP Genetic Data Processing and Digital Products for a 7+ years at CENTOGENE, where she contributed to the successful optimisation and automation of genetic diagnostic and curation related processes. She had the opportunity to get in-depth exposure to big-data analysis and patterns discovery, along with successful proof-of-concept of AI application in variant classification, clinical statement generation and reporting. In 2020, Gabriela was appointed as General Director at Personal Genetics (Bucharest, Romania) where she remarkably implemented the next generation sequencing technology and methodology in house. Finding creative ideas how to improve and optimise „things”, drives her every day.

Fabian joined Arcensus in February 2022 after working a combined 7 years as Finance Executive at Tesla Motors in Europe and CFO of Tesla Automation in Shanghai.

He has extensive experience in structuring dynamic growth and transforming organizations. Fabian is dedicated to continuously improve financial processes and performance by integrating innovative systems. He has a proven record of remarkable achievements in maturing processes and reaching automation.

Having lived in the United States and China for many years, Fabian has an in-depth understanding of intercultural organizations and global challenges. Fabian holds a Global Executive Master in Business Administration with Distinction from Hult Business School and a Bachelor in International Business Management. He is fluent in German, English and Mandarin. 

Michael has worked in the pharmaceutical and biotech industries for 30+ years, with 25+ years as a CEO, business angel and investor in fast-growing biotech, pharma and IT companies. Michael has lived and worked all over the world and in more than 10 countries for companies including Sandoz/Novartis, Abbott, ProBioGen AG and the NASDAQ-listed CENTOGENE. He is highly experienced in building up and reorganising start-ups and technology companies. Today, he is head of the supervisory board of the IT company OXID eSales AG in Freiburg as well as supervisory member of the MBA Programme at the University of Potsdam.

Michael founded Arcensus together with Arndt at the end of 2020.

Michael studied Business in Hamburg and completed an MBA Programme in the UK with the assistance of a BAT scholarship.